Profil
Yves L'Epine is currently the Chairman at Abarem SASU, Abalux SAS, and Mci Falco.
Previously, he served as the Chief Executive Officer at Guerbet SA from 2019 to 2020, Chairman & Chief Executive Officer at Takeda France SAS from 1999 to 2010, and Vice President-Established Products Division at Abbott Laboratories from 2010 to 2011.
Dr. L'Epine holds an MBA from INSEAD and a doctorate from Université de Paris 5 René Descartes.
Aktive Positionen von Yves L'Epine
| Unternehmen | Position | Beginn |
|---|---|---|
| Abarem SASU | Chairman | - |
| Abalux SAS | Chairman | - |
| Mci Falco | Chairman | - |
Ehemalige bekannte Positionen von Yves L'Epine
| Unternehmen | Position | Ende |
|---|---|---|
| GUERBET | Chief Executive Officer | 01.01.2020 |
| ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.2011 |
Takeda France SAS
 Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Chief Executive Officer | 01.01.2010 |
Ausbildung von Yves L'Epine
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| GUERBET | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Université de Paris 5 René Descartes | Consumer Services |
| Abarem SASU | |
| Abalux SAS | |
| Mci Falco | |
Takeda France SAS
Takeda France SAS Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Takeda France SAS is a private company based in Paris, France. The CEOs are Anne-Sylvie Brunel, Sonia Rouges. Takeda France specializes in research and development for innovation in health, with expertise in gastroenterology, hematology, oncology, and rare diseases. The French company is committed to promoting information and studies requiring access to data by health manufacturers. Takeda France also has initiatives for diversity, equity, and inclusion, as well as a policy for the protection of personal data. The company was founded in 1978. | Health Technology |
